Tongrentang Group insists on taking Chinese medicine as the main direction. At present, it has formed five sectors with the pharmaceutical industry as the core, supported by health care, old-age care, commercial retail and international pharmaceutical industry, and built a large health industrial chain integrating planting (breeding), manufacturing, sales, medical care, rehabilitation and research and development.

With the establishment of Tongrentang Sinopharm Group's Hong Kong production base as a symbol, Beijing Tongrentang and China Tongrentang have achieved a leap to the world Tongrentang. At present, business service terminals have been set up in 28 countries and regions on five continents, which has accelerated the pace of internationalization of traditional Chinese medicine.

It has seven sub-groups, two hospitals and several directly affiliated subsidiaries, and more than 2,400 retail terminals and medical institutions, which can provide health services to consumers all the year round. With 36 production bases and more than 1 10 modern production lines, it can produce more than 20 dosage forms in six categories, more than 2,600 kinds of medicines and health foods, and a large number of well-known trump cards such as Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Wuji Baifeng Pill are household names.

It has a national engineering center and a postdoctoral research center, as well as a sound scientific and technological research and development system. Since the "Thirteenth Five-Year Plan", 265 new products have been developed, and Morinda officinalis oligosaccharide capsules won the first prize of Beijing Science and Technology, filling the gap in the treatment of depression with traditional Chinese medicine. Insisting on innovative technology to solve technical problems in the industry has completely changed the backward situation of manual operation in the production of traditional Chinese medicine.